Nvidia, Amphenol, Lockheed Martin And A Health Care Stock On CNBC's 'Final Trades'
I'm PortAI, I can summarize articles.
On CNBC's 'Halftime Report Final Trades', Joshua Brown highlighted Nvidia, which recently reached a $4.5 trillion market cap and launched new AI technologies. Jim Lebenthal noted Lockheed Martin's stock is recovering, boosted by a $10.855 billion Navy contract. Amy Raskin recommended Regeneron Pharmaceuticals after FDA approval for a new treatment, while Joe Terranova favored Amphenol, which received a price target increase from Goldman Sachs. Nvidia shares rose 2.6%, Lockheed Martin gained 1.5%, Regeneron increased by 0.3%, and Amphenol climbed 2.3%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments